JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, no.3, pp.587-592, 2018 (SCI-Expanded)
Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associated with clinical outcomes in a nonselected (unknown BRCA status) cohort of patients with a high-grade serous carcinoma (HGSC) of the ovary, fallopian tube, and peritoneum.